Site-directed mutagenesis of the vnE and rhoE enhancers was performed according to the QuikChange II protocol (Agilent Technologies). vnE and rhoE enhancers were first introduced in pBluescript SK+ vector for site-directed mutagenesis and the resulting mutated enhancers were consequently transferred to pRVV54 for in vivo analysis in the fruit fly. Primers used for mutagenizing of putative binding site are listed in
Plasmids for recombinant protein production were made by introducing cDNA sequences into pET21 series vectors (Novagen-EMD Millipore) and their derivatives, resulting in C-terminally tagged His proteins. Primers used to generate Dll-His (full-length Dll), Sp1Zn-finger-His (only the Zn-finger domains; used for confirming in vitro binding to Sp1 sites), Sp1424AA-His (used to examine cooperativity with Dll), MadMH1-His (only the MH1 domain) and PanHMG-His (only the HMG domain) vectors are listed in